Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 14;15(1):16744.
doi: 10.1038/s41598-025-01334-2.

Klotho plasma levels are an independent predictorof mortality in women with acute coronary syndrome

Affiliations

Klotho plasma levels are an independent predictorof mortality in women with acute coronary syndrome

Marcelino Cortés et al. Sci Rep. .

Abstract

Alterations in plasma levels of the components of the mineral metabolism (MM) system are related to cardiovascular diseases. However, gender differences of the whole MM system in patients with acute coronary syndrome (ACS) have not been reported. Our objective was to analyse the potential differences on the prognostic role of MM in women suffering an ACS as compared to men. We included 1,230 patients with ACS and collected clinical data and plasma levels of MM components. Primary outcome was a composite of acute ischaemic events, heart failure and all-cause mortality. Secondary outcomes included each component separately. 282 patients (22.9%) were female. After 5.44 years of follow-up, primary outcome occurred in 28.0% women and 23.5% men, and death in 10.6% and 9.4% respectively. FGF23 was associated with primary outcome in both sexes, and calcidiol only in men (HR 1.04, CI95%1.00-1.03). Klotho levels are inversely related to all-cause mortality only in women (HR 0.80, CI95% 0.67-0.96), while calcidiol (HR 0.84, CI95%0.72-0.98) and FGF23 levels (HR 1.02 CI95%1.00-1.03) were predictors in men, highlighting a possible gender-specific prognostic biomarker. These results underline the importance of considering MM biomarkers in risk stratification and management of patients with acute coronary syndromes, with attention to gender differences.

Keywords: Acute coronary syndrome; Cardiovascular risk; Gender; Klotho protein; Mineral metabolism.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Study flow chart.

References

    1. Wolf, M. Forging forward with 10 burning questions on FGF23 in kidney disease. J. Am. Soc. Nephrol.21, 1427–1435 (2010). - PubMed
    1. Michos, E. D., Cainzos-Achirica, M., Heravi, A. S., Appel, L. J. & Vitamin, D. Calcium supplements, and implications for cardiovascular health. J. Am. Coll. Cardiol.77, 437–449 (2021). - PubMed
    1. Falkner, B., Keith, S. W., Gidding, S. S. & Langman, C. B. Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males. J. Am. Soc. Hypertens.11, 480–487 (2017). - PMC - PubMed
    1. Panwar, B. et al. Association of fibroblast growth factor 23 with risk of incident coronary heart disease in Community-Living adults. JAMA Cardiol.3, 318–325 (2018). - PMC - PubMed
    1. Liu, M. et al. Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis. Front. Cardiovasc. Med.9, 989574 (2022). - PMC - PubMed

LinkOut - more resources